Vimarsana
Biggest News Aggregation in the World

Page 32 - Rna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rna Today - Breaking & Trending Today

New project combines traditional methods with metaviromics to study viral outbreaks in wild rodents - Vimarsana News

New project combines traditional methods with metaviromics to study viral outbreaks in wild rodents

When, where, and why do diseases jump from animals to people? A new project will monitor how changing seasons, land use, and human behavior influence viral outbreaks in wild rodent populations, to identify hotspots with high potential for spillover into people.

new study - Covid mRNA vax destroys important beneficial bacteria - Vimarsana News

new study - Covid mRNA vax destroys important beneficial bacteria

Bifidobacteria in gut are important in immune system and fighting cancer

COVID proved the therapeutic potential of RNA technology – making it more available is the next goal - Vimarsana News

COVID proved the therapeutic potential of RNA technology – making it more available is the next goal

Considered a pipe dream not too long ago, research on RNA therapeutics is progressing rapidly. Now a new manufacturing protocol will help researchers to advance the technology.

How mRNA technology is creating affordable, potent vaccine products - Vimarsana News

How mRNA technology is creating affordable, potent vaccine products

We took the time to speak with Amy Walker, VP of research, at biotechnology company 4basebio to discuss if synthetic DNA templates represent the future of mRNA production.

Medicine's Hot New Modality, mRNA, Faces Unclear Regulatory Landscape - Vimarsana News

Medicine's Hot New Modality, mRNA, Faces Unclear Regulatory Landscape

Even after the runaway success of mRNA vaccines against COVID-19, the pathway to approval for upcoming would-be mRNA therapeutics has yet to be laid out.